Keefe Bruyette lowered the firm’s price target on Hippo (HIPO) to $33 from $34 and keeps a Market Perform rating on the shares. The path to 2028 carries risks from strong growth against softening pricing, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIPO: